Moya M. Daniels
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Moya M. Daniels
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 16 | |
| Subsidiary | Pharmaceuticals: Major | 15 | |
| Public Company | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Moya M. Daniels via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Comptroller/Controller/Auditor | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MULTICELL TECHNOLOGIES, INC. | Biotechnology | Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Founder Corporate Officer/Principal | |
Amneal Pharmaceuticals LLC
 Amneal Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amneal Pharmaceuticals LLC manufactures and distributes generic pharmaceuticals. It offers buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets and oral solids. The company was founded by Chintu Patel, Chirag K. Patel and Jiten Parikh in June 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Oregon Health & Science University | College/University | Doctorate Degree | |
| University of Rochester School of Medicine & Dentistry | College/University | Doctorate Degree | |
| AT&T INC. | Wireless Telecommunications | Corporate Officer/Principal | |
Dickinson & Co.
 Dickinson & Co. Investment Banks/BrokersFinance Dickinson & Co. is a private company that specializes in security dealing and underwriting. The company is based in Des Moines, IA. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of Rhode Island | College/University | Undergraduate Degree | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| University of California, Irvine | College/University | Doctorate Degree | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| University of California, Riverside | College/University | Undergraduate Degree | |
| University of Georgia | College/University | Graduate Degree | |
| Henley Management College | College/University | Masters Business Admin | |
| Magdalene College | College/University | Graduate Degree | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| New York Stem Cell Foundation, Inc. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
| AVADEL PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Alfred Lerner College of Business & Economics | College/University | Masters Business Admin | |
| Franklin & Marshall College | College/University | Undergraduate Degree | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Sales & Marketing | |
Stemgent, Inc. /New/
 Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Biotechnology | Corporate Officer/Principal | |
Covis Pharmaceuticals, Inc.
 Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Verenigd Koninkrijk | 7 |
| Ierland | 3 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Health Services | 3 |
| Communications | 2 |
Operationeel
| Director/Board Member | 145 |
| Corporate Officer/Principal | 62 |
| Independent Dir/Board Member | 59 |
| Director of Finance/CFO | 43 |
| Chief Executive Officer | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| James Geraghty | 25 |
| Charles Rowland | 25 |
| Gail Naughton | 22 |
| Susan Windham-Bannister | 20 |
| Alexander Pasteur | 19 |
| Jay Moyes | 18 |
| Thomas M. Brandt | 17 |
| Marc Dunoyer | 15 |
| Mark Rothera | 14 |
| Thomas Knapp | 14 |
| Frank Thomas | 14 |
| Alicia Secor | 12 |
| Joanne Beck | 12 |
| Charles A. Reinhart | 12 |
| Stephen M. Chang | 12 |
- Beurs
- Insiders
- Moya M. Daniels
- Bedrijfsconnecties
